Thymopentin and Splenopentin As Immunomodulators Current Stutus
Total Page:16
File Type:pdf, Size:1020Kb
Immunologic Research 1998;17/3:345-368 Thymopentin and Splenopentin as Immunomodulators Current Stutus 1Department of Immunology, Sanjay Gandhi Post-Graduate Institute of Medical Sciences, Lucknow, India. 2Division of Biopolymers, Central Drug Research Institute, Lucknow, India. 3Department of Microbiology, RML Awadh University, Faizabad, India. Abstract Key Words Splenopentin (SP-5, Arg-Lys-Glu-Val-Tyr) and thymopentin (TP-5, Immunomodulation Arg-Lys-Asp-Val-Tyr) are synthetic immunomodulating peptides Splenin corresponding to the region 32-34 of a splenic product called splenin Splenopentin (SP) and the thymic hormone thymopoietin (TP), respectively. TP Thymopoietin was originally isolated as a 5-kDa (49-amino acids) protein from Thymopentin bovine thymus while studying effects of the thymic extracts on neuro- muscular transmission and was subsequently observed to affect T cell differentiation and function. TP I and II are two closely related polypeptides isolated from bovine thymus. A radioimmunoassay for TP revealed a crossreaction with a product found in spleen and lymph node. This product, named splenin, differs from TP only in position 34, aspartic acid for bovine TP and glutamic acid for bovine splenin and it was called TP III as well. Synthetic pentapeptides (TP-5) and (SP-5), reproduce the biological activities of TP and SP, respectively. It is now evident that various forms of TPs were created by proteolytic cleavage of larger proteins during isolation, cDNA clones have been isolated for three alternatively spliced mRNAs that encodes three distinct human T cell TPs. The immunomodulatory properties of TP, SP, TP-5, SP-5 and some of their synthetic analogs reported in the literature have been briefly reviewed. Dr. V. K. Singh 9 1998 345 Laboratory of Molecular Immunology Humana Press Inc. Department of Immunology 0257-277X/98/ Sanjay Gandhi Post-Graduate Institute of Medical Sciences 17/3:345 368/$14.00 Lucknow - 226 014, India E-mail: vksingh @sgpgi.ren.nic.in Introduction nity and decrease the morbidity of immuno- "hnmunomodulators" are substances that compromised individuals (1-3). Similar have the ability to influence various compo- observations were also made in the case of nents of the immune system. They can be used experimental animals (4,5). One of the thymic therapeutically for correcting pathological hormones called thymopoietin (TP) is a aberrations of the immune response in condi- polypeptide consisting of 49 amino acids (6, 7). tions such as immunodeficiency, chronic TP has pleiotropic biological actions includ- infections, autoimmunity, organ transplant ing effects on neuromuscular transmission and neoplasia, and so on. Such substances are (8,9), T and B cell differentiation (10,11) and often referred to as "Biological Response regulation of the immune response (12-17). Modifiers" as well. The action of immuno- The biological activity to TP is reproduced by modulators may be specific or nonspecific. a synthetic pentapeptide thymopentin (TP-5) The pharmacological modulation of the whose amino acid sequence corresponds to the immune response is essentially dependent region 32-36 of the native hormone (Arg-Lys- upon the dose of the substance applied, the Asp-Val-Tyr). Since the pentapeptide (TP-5) mode of its application, and the prevailing sta- exhibits all the biological activities of TP, the tus of the immune system of the host. former is considered to be the active site of the Endeavors to develop chemically well- native hormone (18). Recently, a closely defined compounds possessing immuno- related pentapeptide called splenopentin modulating properties have resulted in the (SP-5), has been reported to exhibit a particu- identification of several classes of compounds larly interesting biological profile. The amino that can act as immunostimulants or immuno- acid sequence ofSP-5 (Arg-Lys-Glu-Val-Tyr) suppressors. Several peptides and their deriva- corresponds to the segment 32-36 of a splenic tives such as muramyl dipeptide (MDP), hormone called "splenin" (also referred as lauroyl tetrapeptide (LTP), enkephalins and TP-III). SP-5 differs from TP-5 only at posi- thymic hormones, are quite well known for tion 3 due to the presence of Glu residue in their immunostimulating activities. Likewise, place of Asp. SP-5 is known to influence both cyclosporin A, FK-506, and rapamycin are early T and B cell differentiation (19), to well-established immunosuppressive agents. increase the number of antibody-forming cells In addition, many substances such as saponins, in mice after gamma irradiation (20,21). This non-ionic block polymers, monophosphoryl pentapeptide accelerates the repopulation of A and cytokines, which stimulate T cell sub- epidermal Langerhans cells at skin sites sets responsible for the manifestation of the depleted with these cells (22,23). Several syn- specific immune responses, are termed thetic analogs of TP-5 and SP-5 have been immunoadjuvants. Interleukin-1 (IL-1) hap- studied for their immunomodulatory activity pens to be the first cytokine that has been used with a view to identify a compound that would as an adjuvant. Administration of interferon-], be more suitable for pharmaceutical applica- (IFN-],) is also known to activate helper T cells tion in terms of stability, biodisposition, and for antibody and delayed-type hypersensi- receptor affinity. Short synthetic peptide tivity responses. sequences of this type may turn out to be ideal In recent years, thymic preparations have candidates as adjuvants for human vaccines been widely used for boosting the natural and could also be utilized as immunothera- defense system of the host. Thymic hormones peutic and immunoprophylactic agents in case have been reported to reverse altered immu- of infectious diseases, immunodeficiencies, 346 Singh et al. Table !. Summary of immunomodulatory activities of TP In vitro studies T cell differentiation Induced prothymocyte to thymocyte differentiation 10 B cell differentiation Inhibited B cell differentiation 11 Lymphocyte proliferation Stronger inducer than synthetic TP-II 48 In vivo studies Neuromuscular transmission Impaired 6 T cells Induced T cell differentiation 50 autoimmune diseases, and cancers. This arti- later found to be wholly crossreactive with cle constitutes an attempt to highlight the TP-I (26). Subsequent studies with synthetic recent developments relating to TP-5 and fragments showed that the pentapeptide SP-5, and to give an idea about their current sequence Arg-Lys-Asp-Val-Tyr, corre- status as immunomodulators. sponding to residues 32-36, was the minimal fragment that reproduced the biologic proper- Thymopoietin ties of TP, both in vitro and in vivo, and this TP is a polypeptide hormone of the thymus synthetic pentapeptide was termed TP-5 (18,19). that induces differentiation of prothymocytes TP is a linear polypeptide hormone secreted to thymocytes and also has secondary by the epithelial cells of the thymus and is effects on neuromuscular transmission (6). Its readily detected in the thymus and absent in immunomodulatoryproperties are summarized control tissues, such as, liver, kidney, thyroid, in Table 1. and muscle (6,27). The isolation of TP-reac- tive material in fetal bovine skin was moni- Isolation and Structure of TP tored by means of a radioimmunoassay. The The similarity of the signs and symptoms of amino acid sequence of this material was myasthenia gravis with those of curare poi- found to be identical with that of TP isolated soning prompted an extensive search for a from the thymus. Experimental evidence sug- curare-like substance in the serum of myas- gests that TP in the circulation is derived from thenic patients or in thymus extracts. How- the thymus and not from the skin, suggesting ever, in the absence of such a substance this that the TP in keratinocytes has a local function, conundrum was solved when the molecules either apocrine or immunoregulatory (28). responsible for the delayed neuromuscular The TP gene is expressed predominantly in impairment in mice were identified following lymphatic tissues. The lymphatic tissue with the injection of thymic extracts or purified the highest levels was observed in thymocytes polypeptides. Two biochemically homoge- and not in thymic stroma. Lower but still sig- neous thymic polypeptides, TP-I and -II were nificant amounts were present in the tonsils, isolated (7). The complete amino acid neck lymph nodes, and small intestines (prob- sequence of TP-II was determined and the bio- ably because of its lymphatic component-- logical activity was shown to reside in seg- Peyer's patches), whereas cultured spleen ment 29-41 by chemical synthesis (24,25). A stromal cells and peripheral blood mono- radioimmunoassay developed for TP-II was nuclear cells displayed a low level of TP lmmunomodu|ationwith TP-5 and SP-5 347 mRNA. The TP gene expression in all other mRNA expression is demonstrated in lympho- (nonlymphatic) tissues tested was weak, cytes from all the differentiation stages inves- barely detectable, or virtually absent (29). tigated, as well as in the myeloid cell line, Harris et al. (30) reported the isolation of K562. The findings suggest a further expan- cDNA clones for three alternatively spliced sion of the proposed ATP functions (33). mRNAs that encode three distinct human TP. A TP-related peptide gene was identified and Proteins encoded by these mRNAs, named cloned from a human cDNA library (34) and TPc~ (75 kDa), 13 (51 kDa), and y (39 kDa), novel TP responsive proteins 1 and 2, related to contained similar N-terminal regions, includ- signal transduction, were also identified (35). ing sequences nearly identical to that of the TP levels in the serum have been found to originally isolated TP, but had divergent be high in normal humans until the fourth C-terminal regions (31). It is now evident that decade of life, after that the levels decline pro- 49-amino acid TPs were created by proteolytic gressively and are below detection limits by cleavage of a larger protein during isolation 70 yr of age (36). These findings parallel the and represent the N-terminal sequences of known anatomic involution of the thymus and these proteins.